Yvette Jones-Holman
Psychiatric/Mental Health · Hawaiian Gardens, CANPI 1205254125
Payments from drug & device makers
Across 729 payments — averaging $23.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Lundbeck LLC$1K
- Teva Pharmaceuticals USA, Inc.$1K
- Alkermes, Inc.$1K
- Johnson & Johnson$1K
- Vanda Pharmaceuticals Inc.$1K
- plus $8K from 36 others
What the payments were for
- Food & beverage$17,15699%
- Education$1701%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,326 in reported general payments places this provider in the 95th percentile of 2,433 psychiatric/mental health providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 34 | $48,723 |
| RexultiBrexpiprazole | 34 | $47,993 |
| SpravatoEsketamine Hcl | 21 | $24,722 |
| AuvelityDextromethorphan Hbr/Bupropion | 15 | $14,971 |
| FetzimaLevomilnacipran Hcl | 12 | $5,800 |
| TrintellixVortioxetine Hydrobromide | 11 | $5,429 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 13 | $3,282 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 129 | $3,048 |
| Quetiapine Fumarate | 225 | $2,915 |
| Olanzapine | 76 | $2,419 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 25 | $2,260 |
| Trazodone Hcl | 137 | $1,917 |
| Paliperidone ErPaliperidone | 27 | $1,834 |
| Divalproex Sodium ErDivalproex Sodium | 19 | $1,684 |
| Fluoxetine Hcl | 27 | $1,624 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar, Fetzima | $3,155 | $54,52346 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,093 | $47,99334 claims |
| Johnson & JohnsonSpravato | $1,129 | $24,72221 claims |
| Axsome Therapeutics, Inc.Auvelity | $595 | $14,97115 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $1,053 | $5,42911 claims |
| Lilly USA, LLCOlanzapine | $42 | $2,41976 claims |
| Almatica Pharma LLCSertraline Hcl | $492 | $32668 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,433 psychiatric/mental health providers in California.
Other psychiatric/mental health in Hawaiian Gardens
- Carey MartinMillbrae$745K
- Liberty MaciasRedlands$288K
- Joshua BurgettSacramento$239K
- Jovita Ezirim-SalamialofojeLos Angeles$162K
- Angie-Kolleen TanThousand Oaks$159K
- Thy LamVista$121K
- David OhIrvine$72K
- Samantha PerkinsAnaheim$49K
- Yvette ElpidioOrange$43K
- Sarah KoLos Angeles$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.